Skip To Main Content
Constanza Perez de la Puente on Muck Rack

Constanza Perez de la Puente

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Constanza Perez

Contact Constanza Perez, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Role of tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer treated with KEYNOTE-522 in real-world setting

|
By Renata Colombo Bonadio, Flávia Cavalcanti Balint, Federico Waisberg, Zenaide Silva de Souza, Débora de Melo Gagliato, Mayana Lopes de Brito, Daniele Assad-Suzuki, Daniela Dornelles Rosa, Laura Testa, María Ferreira, Isadora Martins de Sousa, Matheus de Oliveira Andrade, Mariana Gouveia, Fernanda Madasi, José Bines, Candice Lima Santos, Monique Celeste Tavares, Maira Tavares, Mariana Monteiro, Bruna Zucchetti, Anezka Ferrari, Gilmara Resende, Vanesa López, VANESA lOPEZ, Solange Moraes Sanches, Paulo M Hoff, Romualdo Barroso-Sousa, Constanza Perez de la Puente
| Nature Verified
Abstract Tumor-infiltrating lymphocytes (TILs) are established prognostic and predictive biomarkers in early-stage triple-negative breast cancer (eTNBC), yet their role in patients treated with the KEYNOTE-522 (KN522) regimen remains underexplored.
Open in Who Shared Issue with article?
See all 1 articles